Judge overturns deal giving Purdue Pharma’s Sackler family immunity from opioid claims
The chairman of the company’s board, Steve Miller, said in a statement that the ruling would “delay and perhaps end the ability of creditors, communities, and individuals to receive billions in value to abate the opioid crisis.”